Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Metabolomics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Metabolomics is estimated at US$3.5 Billion in 2023 and is projected to reach US$9 Billion by 2030, growing at a CAGR of 14.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The expansion of metabolomics is driven by several key factors, including advancements in analytical and diagnostic technologies that allow for precise implant placements and the development of materials like zirconia as alternatives to traditional substances like titanium, offering new options for patients. The integration of digital dentistry through CAD/CAM technologies has streamlined implant design and fabrication processes, reducing turnaround times and enhancing customization.
Increased consumer awareness and preferences for durable and aesthetically pleasing solutions such as implants, alongside the growing acceptance of cosmetic dentistry, have significantly contributed to the market demand. Improved insurance coverage and financing options have made these advanced treatments more accessible, broadening the patient base. Additionally, the global rise in the aging population who may require dental restorations further propels the demand for dental implants, ensuring ongoing market growth and innovation.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Biomarker Discovery Application segment, which is expected to reach US$3.6 Billion by 2030 with a CAGR of a 16.0%. The Drug Discovery Application segment is also set to grow at 14.2% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $965.8 Million in 2023, and China, forecasted to grow at an impressive 13.6% CAGR to reach $1.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Key Questions Answered:
- How is the Global Metabolomics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AB Sciex, African Biosciences, Agilent Technologies and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 31 Featured):
- AB Sciex
- African Biosciences
- Agilent Technologies
- Agios Pharmaceuticals
- Berg
- BioCat
- Biocenter Finland
- Biocrates Life Sciences
- Biogenetics
- Bio-Rad Laboratories
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 268 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $3.5 Billion |
| Forecasted Market Value (USD) by 2030 | $9 Billion |
| Compound Annual Growth Rate | 14.4% |
| Regions Covered | Global |
Key Topics Covered:
1. MARKET OVERVIEW
- Metabolomics: Transforming Healthcare with Insight into Metabolic Pathways and Biomarkers
- Global Economic Update
- Competition
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024
- Introduction to Metabolomics
- Analytical Techniques in Metabolomics
- The Metabolomics Workflow: Key Stages
- Applications of Metabolomics
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
- AB Sciex
- African Biosciences
- Agilent Technologies
- Agios Pharmaceuticals
- Berg
- BioCat
- Biocenter Finland
- Biocrates Life Sciences
- Biogenetics
- Bio-Rad Laboratories
3. MARKET TRENDS & DRIVERS
- Development of Novel Biomarkers for Disease Detection Drives Widespread Adoption of Metabolomics in Clinical Diagnostics
- Metabolomics in Drug Research and Development: A Pathway to Precision Medicine
- Growing Focus on Personalized Healthcare and Patient-Centric Solutions Expands Addressable Market for Targeted Metabolomics Applications
- Growing Multidisciplinary Role of Metabolomics in Toxicology Testing
- Rising Demand for Nutrigenomics Throws the Spotlight on Nutritional Metabolomics Applications for Customized Diet Planning
- Growing Investment in Cancer Research Propels Growth in Oncology-Focused Metabolomics Studies and Applications
- Integration of AI, Machine Learning, and Big Data Analytics Expands the Potential of Metabolomics Data for Predictive Modeling and Insights
- Advancements in Mass Spectrometry and Analytical Tools Strengthen the Business Case for Large-Scale Metabolomics Research
- Global Shift Toward Precision Medicine Accelerates Adoption Of Metabolomics
- Role of Metabolomics in Inborn Errors of Metabolism (IEMs): Current Advancements and Future Directions
- Harnessing Metabolomics for Crop Improvement and Sustainable Agriculture
4. GLOBAL MARKET PERSPECTIVE
For more information about this report visit https://www.researchandmarkets.com/r/ym31jm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
